LinkedIn automations are now retired. TexAu V3 is on the way, be the first to know when it launches.

Get updates

How Much Did Viz.ai Raise? Headquarters, Funding & Key Investors

Viz.ai has raised a total of $252 million in funding across multiple rounds, including a $40 million Conventional Debt round in March 2023, a $100 million Series D in April 2022, and a $71 million Series C in March 2021, reaching a $1.2 billion valuation. Founded in 2016 by Chris Mansi and David Golan, the San Francisco-based company develops AI-powered healthcare solutions that accelerate disease detection and care coordination. Backed by investors such as Insight Partners, Tiger Global Management, and Innovation Endeavors, Viz.ai is transforming emergency healthcare workflows worldwide.

    Viz.ai is a healthcare technology company that provides an AI-powered care coordination platform to assist in disease detection and treatment, with a focus on neurology. The platform is designed to aid in emergency medical cases, particularly in stroke diagnosis, by analyzing patient scans, identifying patterns of medical conditions, and categorizing imaging data. The company has raised $252M in funding from investors such as Insight Partners, Tiger Global Management, and Innovation Endeavors, and is currently valued at $1.2B.

    What Is Viz.ai and What Does It Do?

    Viz.ai, founded in 2016 by Chris Mansi and David Golan, is headquartered in San Francisco, United States. The company employs 206 people and specializes in AI-driven healthcare solutions that improve care coordination and speed up critical medical decisions.

    The platform compares patient scans to large datasets, identifying patterns indicative of strokes and other neurological conditions. By automating detection and triage workflows, Viz.ai enables hospitals to respond faster, improving patient outcomes. The platform also categorizes scans by situation, helping clinicians prioritize and manage care more efficiently.

    How Much Funding Has Viz.ai Raised?

    1. Conventional Debt

    • Amount Raised: $40M
    • Date: March 2023
    • Lead Investors: Canadian Imperial Bank of Commerce
    • Motivation: To provide additional capital for operations and growth.

    2. Series D

    • Amount Raised: $100M
    • Date: April 2022
    • Lead Investors: Tiger Global Management, Insight Partners, Scale Venture Partners, Kleiner Perkins, Threshold, CRV, Google Ventures, Susa Ventures, Pear VC, Sozo Ventures
    • Motivation: To scale AI platform adoption, expand healthcare partnerships, and enhance platform capabilities.

    3. Series C

    • Amount Raised: $71M
    • Date: March 2021
    • Lead Investors: Scale Venture Partners, Insight Partners, Greenoaks, Kleiner Perkins, Threshold, Innovation Endeavors, Susa Ventures, CRV
    • Motivation: To accelerate product development and expand clinical deployments.

    Total Funding Raised: $252 Million

    Current Valuation: $1.2 Billion (as of April 2022)

    Latest Funding Date: March 2023

    Key Investors

    1. Tiger Global Management

    • Details: Leading investment firm focusing on technology and growth-stage companies.
    • Investment Focus Areas: Technology, healthcare, AI.
    • Notable Investments: Freshworks, Stripe, UiPath.

    2. Insight Partners

    • Details: Venture capital and private equity firm investing in software and technology companies.
    • Investment Focus Areas: Enterprise software, AI, healthcare tech.
    • Notable Investments: Shopify, WalkMe, Pluralsight.

    3. Innovation Endeavors

    • Details: Venture capital firm founded by Eric Schmidt, focusing on early-stage tech companies.
    • Investment Focus Areas: AI, healthcare, enterprise tech.
    • Notable Investments: Planet Labs, Samsara, Cloudflare.

    Where Is Viz.ai’s Headquarters?

    Viz.ai is headquartered in San Francisco, California, providing access to a leading healthcare and technology ecosystem, abundant AI talent, and strong partnerships with hospitals and research institutions.

    What’s Next for Viz.ai?

    Viz.ai aims to expand adoption of its AI care coordination platform across hospitals worldwide, improve diagnostic speed and accuracy, and integrate additional disease detection capabilities. With the recent funding rounds and growing clinical deployments, the company is positioned to lead the AI-driven transformation of emergency healthcare workflows, particularly in neurology and critical care.

    Get Investor & Funding Insights with TexAu

    TexAu helps sales and business teams uncover detailed fundraising information on companies like Viz.ai. Use the platform to research investors, track funding rounds, and gather actionable insights to strengthen prospecting and business strategy.

    Sign Up for Free on TexAu and start uncovering detailed funding insights that give your business a competitive edge.

    Start your 14-day free trial today, no card needed

    TexAu updates, tips and blogs delivered straight to your inbox.